Central to spatial biology is the mapping of cell types across heterogenous tissues. This process helps us understand the relationship between cells in the context of disease and their role in response to treatment. Based on cell abundances, we identified different microenvironment cell subtypes within non-small-cell lung cancer (NSCLC) tissues and differentiated how they responded to checkpoint inhibitor therapy.
Download our application note to learn more: